| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Fabio Marra | Q37841541 |
| Gianluca Tell | Q39599984 | ||
| Claudio Tiribelli | Q41817157 | ||
| Amalia Gastaldelli | Q43294287 | ||
| Gianluca Svegliati-Baroni | Q72323940 | ||
| P2093 | author name string | Gianluca Svegliati Baroni | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatohepatitis | Q2335423 |
| P304 | page(s) | 72-81 | |
| P577 | publication date | 2008-01-22 | |
| P1433 | published in | Trends in Molecular Medicine | Q15265842 |
| P1476 | title | Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis | |
| P478 | volume | 14 |
| Q95839771 | A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice |
| Q41833222 | A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet |
| Q27339224 | A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice |
| Q92644830 | A nonalcoholic fatty liver disease cirrhosis model in gerbil: the dynamic relationship between hepatic lipid metabolism and cirrhosis |
| Q50222903 | A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice. |
| Q45057647 | A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH). |
| Q42534791 | AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability |
| Q37898415 | ASH and NASH. |
| Q36826832 | Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. |
| Q86506810 | Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH |
| Q54317961 | Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats. |
| Q39068056 | Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity. |
| Q36642354 | Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease |
| Q36174255 | Altered arsenic disposition in experimental nonalcoholic fatty liver disease |
| Q41965652 | Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress |
| Q40707212 | Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative |
| Q37814048 | Animal models of nonalcoholic fatty liver disease |
| Q43174499 | Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis |
| Q51308794 | Anti-hyperlipidemic effect of methanol bark extract of Terminalia chebula in male albino Wistar rats. |
| Q53254492 | Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. |
| Q38228503 | Autophagy and microRNA dysregulation in liver diseases |
| Q53092402 | Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice. |
| Q91780954 | Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease |
| Q83259351 | Burning hepatic fat: therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease |
| Q34769732 | CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model |
| Q37624585 | CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). |
| Q47074172 | Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish |
| Q57191819 | Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders |
| Q30478907 | Ceramide-Mediated Insulin Resistance and Impairment of Cognitive-Motor Functions |
| Q37134791 | Characterization of long non-coding RNA transcriptome in high-energy diet induced nonalcoholic steatohepatitis minipigs |
| Q47718804 | Chunggan extract (CGX), methionine-and choline-deficient (MCD) diet-induced hepatosteatosis and oxidative stress in C57BL/6 mice |
| Q33946576 | Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study |
| Q21559453 | Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains |
| Q46401825 | Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis |
| Q36067604 | Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity |
| Q42861751 | Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet |
| Q34613675 | Curcumin limits the fibrogenic evolution of experimental steatohepatitis. |
| Q42345064 | Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives. |
| Q26861308 | Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products |
| Q36383992 | Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice |
| Q28507402 | Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice |
| Q34359482 | Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease |
| Q34180476 | Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease |
| Q36480570 | Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran. |
| Q64944611 | Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells. |
| Q35043473 | Effects of ferulic acid and γ-oryzanol on high-fat and high-fructose diet-induced metabolic syndrome in rats |
| Q51593895 | Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium/calmodulin-dependent kinase kinase-AMP-activated protein kinase-mechanistic target of rapamycin-p70 ribosomal S6 kinase sign |
| Q34643771 | Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. |
| Q33748530 | Enhanced amelioration of high-fat diet-induced fatty liver by docosahexaenoic acid and lysine supplementations |
| Q38569922 | Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet |
| Q50228331 | Enhancing the hepatic protective effect of genistein by oral administration with stachyose in mice with chronic high fructose diet consumption. |
| Q28661241 | Environmental pollution: a tangible risk for NAFLD pathogenesis |
| Q64234550 | Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice |
| Q52783790 | Establishment of a mouse model of enalapril-induced liver injury and investigation of the pathogenesis. |
| Q40818105 | Ethanol extract of Cirsium japonicum attenuates hepatic lipid accumulation via AMPK activation in human HepG2 cells |
| Q38137185 | Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. |
| Q33886936 | Experimental models of non-alcoholic fatty liver disease in rats |
| Q35776345 | FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis |
| Q33675416 | Fast food diet with CCl4 micro-dose induced hepatic-fibrosis--a novel animal model |
| Q37636566 | Fatty liver in childhood |
| Q34185998 | Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes |
| Q89624033 | From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options |
| Q57110508 | Gene-by-Environment Interaction of Bcrp-/- and MCD Diet-Induced Nonalcoholic Steatohepatitis Alters SN-38 Disposition |
| Q31149434 | Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease |
| Q34241720 | Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis |
| Q35581153 | Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer |
| Q35172679 | HCC development is associated to peripheral insulin resistance in a mouse model of NASH. |
| Q53083755 | Hairy and enhancer of split 6 prevents hepatic lipid accumulation through inhibition of Pparg2 expression. |
| Q35070019 | Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans |
| Q37412422 | Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet |
| Q36042132 | Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2 |
| Q37238258 | Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons |
| Q42581790 | Hepatic wound repair |
| Q92924743 | Hepatocyte TNF Receptor-Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6-Linked Polyubiquitination of Apoptosis Signal-Regulating Kinase 1 |
| Q91999800 | Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity |
| Q33896110 | High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism |
| Q50625684 | High-fat diet inhibits PGC-1α suppressive effect on NFκB signaling in hepatocytes. |
| Q36049336 | Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigs |
| Q43196846 | Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. |
| Q37376114 | IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis |
| Q36483906 | Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice |
| Q47125411 | In vivo redox metabolic imaging of mitochondria assesses disease progression in non-alcoholic steatohepatitis |
| Q37258329 | Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? |
| Q35102604 | Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis |
| Q45991426 | Inhibition of DNA-dependent protein kinase reduced palmitate and oleate-induced lipid accumulation in HepG2 cells. |
| Q39672749 | Inhibition of LXRα-Dependent Steatosis and Oxidative Injury by Liquiritigenin, a Licorice Flavonoid, as Mediated with Nrf2 Activation |
| Q33824907 | Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization |
| Q39531917 | Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. |
| Q37602608 | Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. |
| Q36329819 | Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism |
| Q36082853 | Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device |
| Q36980196 | Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes |
| Q46430962 | Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice. |
| Q42717812 | Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines |
| Q36561514 | LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease |
| Q36014318 | Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis |
| Q35603855 | Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay |
| Q37714392 | Limited therapeutic effect of N-acetylcysteine on hepatic insulin resistance in an experimental model of alcohol-induced steatohepatitis |
| Q28538284 | Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells |
| Q34103693 | Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease |
| Q45975745 | Liver damage is not reversed during the lean period in diet-induced weight cycling in mice. |
| Q85939448 | Liver injury attenuation by curcumin in a rat NASH model: an Nrf2 activation-mediated effect? |
| Q30586373 | Longitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice |
| Q46270590 | Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH. |
| Q35860542 | Loss of the Mono-ADP-ribosyltransferase, Tiparp, Increases Sensitivity to Dioxin-induced Steatohepatitis and Lethality |
| Q89717396 | Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes |
| Q37886792 | Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease |
| Q35997878 | Mechanisms of ceramide-mediated neurodegeneration |
| Q35156418 | Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis |
| Q35474335 | Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. |
| Q37707796 | Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease |
| Q64998536 | MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway. |
| Q30439971 | MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma |
| Q36294146 | Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis |
| Q37815476 | Mitochondria and redox signaling in steatohepatitis |
| Q64936740 | Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis. |
| Q35685717 | Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice |
| Q48318207 | Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats |
| Q35776660 | Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis |
| Q36354548 | Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes |
| Q64927843 | Multi-omics Analysis of Liver Infiltrating Macrophages Following Ethanol Consumption. |
| Q36961972 | Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis. |
| Q34533851 | Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice |
| Q26824416 | Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan |
| Q33855157 | Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. |
| Q39413692 | Nonalcoholic Steatohepatitis Modulates Membrane Protein Retrieval and Insertion Processes |
| Q28079077 | Nonalcoholic fatty liver disease - A multisystem disease? |
| Q38052858 | Nonalcoholic fatty liver disease and atherosclerosis |
| Q33886930 | Nonalcoholic fatty liver disease and polycystic ovary syndrome |
| Q38430909 | Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms |
| Q27692035 | Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. |
| Q37387718 | Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice |
| Q26825517 | Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease |
| Q38606360 | Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD. |
| Q62726659 | Oxidative Stress Mechanisms in Hepatocarcinogenesis |
| Q35716234 | PDIA3 Knockdown Exacerbates Free Fatty Acid-Induced Hepatocyte Steatosis and Apoptosis |
| Q91992943 | PPAR δ inhibition protects against palmitic acid-LPS induced lipidosis and injury in cultured hepatocyte L02 cell |
| Q35928495 | Pathogenesis of nonalcoholic steatohepatitis |
| Q37898424 | Pathophysiology of non-alcoholic steatohepatitis and basis for treatment |
| Q37592952 | Pediatric non-alcoholic fatty liver disease: an increasing public health issue. |
| Q42948190 | Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention |
| Q44904802 | Pharmacokinetics of Morphine in Rats with Adjuvant-induced Arthritis. |
| Q91854944 | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling |
| Q34796362 | Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet |
| Q91827824 | Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice |
| Q36273224 | Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer |
| Q62067006 | Profiling microRNA expression: A snapshot of nonalcoholic steatohepatitis and a recording of its pathogenesis |
| Q43263202 | Protective effect of apricot (Prunus armeniaca L.) on hepatic steatosis and damage induced by carbon tetrachloride in Wistar rats. |
| Q42244880 | Protective effect of the Y220C mutant p53 against steatosis: good news? |
| Q39155883 | Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats |
| Q34821020 | Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players |
| Q33830140 | Redox control of liver function in health and disease |
| Q24656684 | Redox mechanisms in hepatic chronic wound healing and fibrogenesis |
| Q64955233 | Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. |
| Q37291238 | Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks |
| Q38209324 | Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools |
| Q42580307 | Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease |
| Q51791871 | Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. |
| Q44921765 | Sex-dependent differences in rat brown adipose tissue mitochondrial biogenesis and insulin signaling parameters in response to an obesogenic diet |
| Q51368985 | Sex-dependent differences in rat hepatic lipid accumulation and insulin sensitivity in response to diet-induced obesity. |
| Q34963206 | Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines |
| Q37353943 | Steatocholecystitis and fatty gallbladder disease |
| Q28396388 | Sustained proliferation in cancer: Mechanisms and novel therapeutic targets |
| Q33509626 | Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology |
| Q57132035 | Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model |
| Q35129349 | Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals |
| Q37587875 | Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. |
| Q54634658 | Teucrium polium reversed the MCD diet-induced liver injury in rats. |
| Q38286011 | The CBS/CSE system: a potential therapeutic target in NAFLD? |
| Q92461377 | The Circulating Micro-RNAs (-122, -34a and -99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases |
| Q36246806 | The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model |
| Q36329899 | The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis |
| Q37863129 | The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful |
| Q34389714 | The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis |
| Q39382140 | The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes. |
| Q38723669 | The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). |
| Q36243894 | Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice |
| Q34023427 | Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis |
| Q35579538 | Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease |
Search more.